Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jul;60(1):38-44.
doi: 10.1016/j.plasmid.2008.03.004. Epub 2008 May 14.

Bacterial Conjugation-Based Antimicrobial Agents

Affiliations
Review

Bacterial Conjugation-Based Antimicrobial Agents

Marcin Filutowicz et al. Plasmid. .

Abstract

A clear imperative exists to generate radically different antibacterial technologies that will reduce the usage of conventional chemical antibiotics. Here we trace one route into this new frontier of drug discovery, a concept that we call the bacterial conjugation-based technologies (BCBT). One of the objectives of the BCBT is to exploit plasmid biology for combating the rising tide of antibiotic-resistant bacteria. Specifically, the concept utilizes conjugationally delivered plasmids as antimicrobial agents, and it builds on the accumulated work of many scientists dating back to the discoveries of conjugation and plasmids themselves. Each of the individual components that comprise the approach has been demonstrated to be feasible. We discuss the properties of bacterial plasmids to be employed in BCBT.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

Substances

LinkOut - more resources

Feedback